Dyne Therapeutics, Inc. Earnings Per Share (Basic)
Dyne Therapeutics, Inc. (DYN) reported Earnings Per Share (Basic) of -$1.08 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-29.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-07-29
- Dyne Therapeutics, Inc. earnings per share, basic for the quarter ending 2026-06-30 was -$1.08.
- Dyne Therapeutics, Inc. earnings per share, basic for the quarter ending 2026-03-31 was -$0.73.
- Dyne Therapeutics, Inc. earnings per share, basic for the quarter ending 2025-09-30 was -$0.76.
- Dyne Therapeutics, Inc. earnings per share, basic for the quarter ending 2025-06-30 was -$0.97.
- Dyne Therapeutics, Inc. earnings per share, basic for fiscal 2025 was -$3.47.
- Dyne Therapeutics, Inc. earnings per share, basic for fiscal 2024 was -$3.37.
- Dyne Therapeutics, Inc. earnings per share, basic for fiscal 2023 was -$3.95.
- Dyne Therapeutics, Inc. earnings per share, basic for fiscal 2022 was -$3.23.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$1.08 10-Q · filed 2026-07-29 | -$1.81 10-Q · filed 2026-07-29 | ||
| 2026-03-31 | -$0.73 10-Q · filed 2026-05-11 | |||
| 2025-12-31 | -$3.47 10-K · filed 2026-03-02 | |||
| 2025-09-30 | -$0.76 10-Q · filed 2025-11-05 | -$2.74 10-Q · filed 2025-11-05 | ||
| 2025-06-30 | -$0.97 10-Q · filed 2026-07-29 | -$2.02 10-Q · filed 2026-07-29 | ||
| 2025-03-31 | -$1.05 10-Q · filed 2026-05-11 | |||
| 2024-12-31 | -$3.37 10-K · filed 2026-03-02 | |||
| 2024-09-30 | -$0.96 10-Q · filed 2025-11-05 | -$2.49 10-Q · filed 2025-11-05 | ||
| 2024-06-30 | -$0.70 10-Q · filed 2025-07-28 | -$1.51 10-Q · filed 2025-07-28 | ||
| 2024-03-31 | -$0.81 10-Q · filed 2025-05-08 | |||
| 2023-12-31 | -$3.95 10-K · filed 2026-03-02 | |||
| 2023-09-30 | -$0.99 10-Q · filed 2024-11-12 | -$2.86 10-Q · filed 2024-11-12 | ||
| 2023-06-30 | -$1.08 10-Q · filed 2024-08-12 | -$1.88 10-Q · filed 2024-08-12 | ||
| 2023-03-31 | -$0.78 10-Q · filed 2024-05-02 | |||
| 2022-12-31 | -$3.23 10-K · filed 2025-02-27 | |||
| 2022-09-30 | -$0.80 10-Q · filed 2023-10-30 | -$2.50 10-Q · filed 2023-10-30 | ||
| 2022-06-30 | -$1.01 10-Q · filed 2023-08-03 | -$1.70 10-Q · filed 2023-08-03 | ||
| 2022-03-31 | -$0.69 10-Q · filed 2023-05-11 | |||
| 2021-12-31 | -$2.93 10-K · filed 2023-03-02 | |||
| 2021-09-30 | -$0.83 10-Q · filed 2022-11-03 | -$1.92 10-Q · filed 2022-11-03 | ||
| 2021-06-30 | -$0.58 10-Q · filed 2022-08-04 | -$1.09 10-Q · filed 2022-08-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Arcus Biosciences, Inc. (RCUS) | United States | $3.188B | -8.52 |
| Arcutis Biotherapeutics, Inc. (ARQT) | United States | $3.303B | 115.47 |
| Enliven Therapeutics, Inc. (ELVN) | United States | $3.307B | -35.07 |
| Amylyx Pharmaceuticals, Inc. (AMLX) | United States | $3.361B | -13.15 |
| PRECIGEN, INC. (PGEN) | United States | $2.757B | -12.94 |
| NewAmsterdam Pharma Co N.V. (NAMS) | $2.719B | -15.37 | |
| MBX Biosciences, Inc. (MBX) | United States | $2.664B | -25.36 |
| IDEAYA Biosciences, Inc. (IDYA) | United States | $3.540B | -20.52 |
| Organon & Co. (OGN) | United States | $3.603B | 17.03 |
| Disc Medicine, Inc. (IRON) | United States | $2.553B | -11.40 |